-
Contract/Tender
-
Posted 10 months ago
Notice of Change: Extension of PAR-21-163 Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3)
at
National Institutes of Health
in
United States
0
0
National Institutes of Health
